\-\ Texto\\:\\ \ \(0\)\
\-\ none\\ provided\ \(5\)\
\-\ surgical\\ resection\\.\ \(23\)\
\-\ there\\ is\\ a\\ very\\ large\\,\\ well\\ circumscribed\\ 26\\ x\\ 23\\ x\\ 23\\ cm\\ mass\\ occupying\\ a\\ majority\\ of\\ the\\ intraperitoneal\\ cavity\\ and\\ which\\ causes\\ mass\\ effect\\ on\\ adjacent\\ structures\\ such\\ as\\ bowel\\ and\\ abdominal\\ aorta\\.\\ there\\ are\\ a\\ few\\ scattered\\ central\\ areas\\ of\\ low\\ attenuation\\ within\\ this\\ mass\\ which\\ have\\ average\\ hounsfield\\ values\\ of\\ approx\\ \\-40hu\\.\ \(0\)\
\-\ myxoid\\ liposarcoma\ \(4\)\
\-\ sarcoma\ \(742\)\
\-\ teratoma\ \(130\)\
\-\ liposar\ \(53\)\
\-\ pleomorphic\\ undifferentiated\\ sarcoma\\ \\(pus\\)\\ \\(aka\\ malignant\\ fibrous\\ histiocytoma\\ or\\ \\ \\ fibrosarcoma\\)\ \(0\)\
\-\ a\\ 62\\ year\\ old\\ man\\ with\\ a\\ large\\ abdominal\\ mass\\.\ \(0\)\
\-\ this\\ patient\\ had\\ been\\ imaged\\ previously\\ at\\ an\\ outside\\ facility\\ and\\ was\\ referred\\ to\\ us\\ for\\ definitive\\ diagnosis\\ and\\ treatment\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sarcoma\\:\\ 0\\.21644215139901762\ \(0\)\
\-\ 23\\:\\ 0\\.21275354443626468\ \(0\)\
\-\ liposar\\:\\ 0\\.20631173741180825\ \(0\)\
\-\ mass\\:\\ 0\\.19711031492787628\ \(0\)\
\-\ undifferentiated\\:\\ 0\\.16397970917162652\ \(0\)\
\-\ myxoid\\:\\ 0\\.1623037089998419\ \(0\)\
\-\ fibrosarcoma\\:\\ 0\\.16074339016903927\ \(0\)\
\-\ aka\\:\\ 0\\.15791274397814245\ \(0\)\
\-\ hounsfield\\:\\ 0\\.15313385087132153\ \(0\)\
\-\ pus\\:\\ 0\\.15107646471610348\ \(0\)\
\-\ histiocytoma\\:\\ 0\\.14919073519410747\ \(0\)\
\-\ approx\\:\\ 0\\.14745021100465427\ \(0\)\
\-\ abdominal\\:\\ 0\\.14111569909696003\ \(0\)\
\-\ occupying\\:\\ 0\\.14032444743364242\ \(0\)\
\-\ imaged\\:\\ 0\\.1385612962759667\ \(0\)\
\-\ liposarcoma\\:\\ 0\\.13800285672161713\ \(0\)\
\-\ intraperitoneal\\:\\ 0\\.13692571729966427\ \(0\)\
\-\ average\\:\\ 0\\.13443797524010204\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.130551469486944\ \(0\)\
\-\ large\\:\\ 0\\.129278736330101\ \(0\)\
\-\ facility\\:\\ 0\\.12793185735782595\ \(0\)\
\-\ 62\\:\\ 0\\.12288532026517024\ \(0\)\
\-\ values\\:\\ 0\\.11899881451201216\ \(0\)\
\-\ definitive\\:\\ 0\\.11783878317251453\ \(0\)\
\-\ which\\:\\ 0\\.11732236288936017\ \(0\)\
\-\ majority\\:\\ 0\\.11717029156230269\ \(0\)\
\-\ scattered\\:\\ 0\\.11225588134702949\ \(0\)\
\-\ teratoma\\:\\ 0\\.11155996019694592\ \(0\)\
\-\ few\\:\\ 0\\.10943563076783114\ \(0\)\
\-\ and\\:\\ 0\\.10663162283387002\ \(0\)\
\-\ cavity\\:\\ 0\\.10651342310429024\ \(0\)\
\-\ provided\\:\\ 0\\.10583827885309736\ \(0\)\
\-\ 26\\:\\ 0\\.10479829549566631\ \(0\)\
\-\ aorta\\:\\ 0\\.10479829549566631\ \(0\)\
\-\ previously\\:\\ 0\\.10356215981227568\ \(0\)\
\-\ outside\\:\\ 0\\.10356215981227568\ \(0\)\
\-\ there\\:\\ 0\\.10266369613245376\ \(0\)\
\-\ us\\:\\ 0\\.10261970457707903\ \(0\)\
\-\ fibrous\\:\\ 0\\.10021384229995649\ \(0\)\
\-\ circumscribed\\:\\ 0\\.09990473972716425\ \(0\)\
\-\ attenuation\\:\\ 0\\.09870892007456629\ \(0\)\
\-\ causes\\:\\ 0\\.09748104657150385\ \(0\)\
\-\ structures\\:\\ 0\\.09693606471041179\ \(0\)\
\-\ referred\\:\\ 0\\.09545966305512055\ \(0\)\
\-\ very\\:\\ 0\\.09254509968871234\ \(0\)\
\-\ malignant\\:\\ 0\\.09196143754432497\ \(0\)\
\-\ effect\\:\\ 0\\.09049735567938831\ \(0\)\
\-\ this\\:\\ 0\\.08865888404901182\ \(0\)\
\-\ areas\\:\\ 0\\.08758742578642684\ \(0\)\
\-\ central\\:\\ 0\\.08615011545931693\ \(0\)\
\-\ adjacent\\:\\ 0\\.08362295107770053\ \(0\)\
\-\ such\\:\\ 0\\.08298446461787057\ \(0\)\
\-\ bowel\\:\\ 0\\.08279157941580463\ \(0\)\
\-\ resection\\:\\ 0\\.08269575023491522\ \(0\)\
\-\ of\\:\\ 0\\.07573883246091802\ \(0\)\
\-\ been\\:\\ 0\\.0751614710826973\ \(0\)\
\-\ cm\\:\\ 0\\.07409070765538826\ \(0\)\
\-\ low\\:\\ 0\\.07402543877068679\ \(0\)\
\-\ none\\:\\ 0\\.070502008401957\ \(0\)\
\-\ man\\:\\ 0\\.06829839072782959\ \(0\)\
\-\ diagnosis\\:\\ 0\\.06687678753378667\ \(0\)\
\-\ have\\:\\ 0\\.06444652864928008\ \(0\)\
\-\ had\\:\\ 0\\.06427648534555305\ \(0\)\
\-\ surgical\\:\\ 0\\.06270205378240364\ \(0\)\
\-\ well\\:\\ 0\\.062466267255484605\ \(0\)\
\-\ treatment\\:\\ 0\\.061453314168061525\ \(0\)\
\-\ within\\:\\ 0\\.05941706641802579\ \(0\)\
\-\ as\\:\\ 0\\.051827057046264266\ \(0\)\
\-\ an\\:\\ 0\\.04933219274752663\ \(0\)\
\-\ are\\:\\ 0\\.0489526356009707\ \(0\)\
\-\ at\\:\\ 0\\.048727921800503386\ \(0\)\
\-\ was\\:\\ 0\\.04496053479240931\ \(0\)\
\-\ or\\:\\ 0\\.04487955564256392\ \(0\)\
\-\ patient\\:\\ 0\\.041959797637233315\ \(0\)\
\-\ year\\:\\ 0\\.039757698726123905\ \(0\)\
\-\ for\\:\\ 0\\.03910130822601213\ \(0\)\
\-\ on\\:\\ 0\\.038962604001893865\ \(0\)\
\-\ old\\:\\ 0\\.038181153246030344\ \(0\)\
\-\ is\\:\\ 0\\.035329693356465346\ \(0\)\
\-\ to\\:\\ 0\\.03225172474906333\ \(0\)\
\-\ the\\:\\ 0\\.025741753130243534\ \(0\)\
\-\ with\\:\\ 0\\.025261362131755286\ \(0\)\
